Bio-Techne (TECH) EBT Margin (2009 - 2026)

Bio-Techne's EBT Margin history runs 18 years deep, the most recent figure standing at 22.87% for Q1 2026.

• In Q1 2026, EBT Margin rose 1077.0% year-over-year to 22.87%; the TTM figure through Mar 2026 stood at 4.98% (down 760.0% YoY), while the FY2025 annual figure was 0.96%, down 1413.0% from the prior year.
• EBT Margin was 22.87% for Q1 2026 at Bio-Techne, up from 17.16% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 5185.8% in Q3 2022 to a low of 34.6% in Q2 2025.
• Historically, EBT Margin has averaged 320.05% across 5 years, with a median of 17.9% in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT Margin soared 515965 bps in 2022, then sank 516790 bps in 2023.
• A 5-year view of EBT Margin shows it stood at 24.46% in 2022, then sank by 50 bps to 12.25% in 2023, then grew by 18 bps to 14.43% in 2024, then advanced by 19 bps to 17.16% in 2025, then jumped by 33 bps to 22.87% in 2026.
• The last three EBT Margin figures came in at 22.87% (Q1 2026), 17.16% (Q4 2025), and 16.75% (Q3 2025), per Business Quant data.